Phillip C. Yang, MD
Academic Appointments
- Associate Professor - Med Center Line, Medicine - Cardiovascular Medicine
- Member, Bio-X
Key Documents
Contact Information
-
Clinical Offices
Cardiovascular Medicine Clinic 300 Pasteur Dr MC 5319 A260 Stanford, CA 94305 Tel Work (650) 723-6459 Fax (650) 724-4034
- Academic Offices
Personal Information Email Tel (650) 723-8138Alternate Contact Brian Habekoss Administrative Associate Tel Work (650) 498-4805Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cardiology (Heart)
- Cardiovascular Disease
Administrative Appointments
- Assistant Professor, Stanford Division of Cardiovascular Medicine (2005 - present)
- Clinical Instructor & Staff Physician, Stanford Division of Cardiovascular Medicine (1999 - 2005)
- Cardiology Fellow, Stanford Division of Cardiovascular Medicine (1994 - 1999)
Honors and Awards
- Melvin Judkins Young Investigator Award, 1st Place, senior author, American Heart Association (2011)
- Melvin Judkins Young Investigator Award, 1st Place, senior author, American Heart Association (2010)
- Melvin Judkins Young Investigator Award, 1st Place, senior author, American Heart Association (2009)
- Judge, Young Investigator Awards Competition: Physiology, Pharmacology, and Pathology, American College of Cardiology (2008)
- Young Investigator Award, Finalist, American College of Cardiology (2007)
- Vivien Thomas Young Investigator Award, American Heart Association (2005)
Professional Education
| Fellowship: | Stanford University School of Medicine CA (1998) |
| Board Certification: | Echocardiography, National Board of Echocardiography (2008) |
| Board Certification: | Cardiovascular Disease, American Board of Internal Medicine (1999) |
| Residency: | UCLA Medical Center CA (1993) |
| Internship: | UCLA - School of Medicine CA (1990) |
| Medical Education: | Yale University School of Medicine-Graduate CT (1989) |
Community and International Work
Scientific Focus
Current Research Interests
Dr. Yang's research focuses on comprehensive evaluation of myocardial injury and restoration using novel molecular and cellular MRI techniques. By combining the chemical sensitivity of nuclear magnetic resonance with high spatial and temporal resolution, integrated imaging of a wide range of regenerative processes in the cardiovascular system is possible. This innovative approach enables in vivo imaging of stem cell biology and their effects on the myocardium. The novel MRI techniques are employed to investigate a broad spectrum of cardiovascular stem cells derived from human pluripotent and adult stem cells. Dr. Yang's research has been supported by the National Institutes of Health, American Heart Association, California Institute of Regenerative Medicine, Stanford Cardiovascular Institute, and private organizations.
Publications
- Apelin enhances directed cardiac differentiation of mouse and human embryonic stem cells. PLoS One. 2012; (6): e38328
- Bone marrow cell therapy in clinical trials: a review of the literature. Rev Recent Clin Trials. 2012; (3): 204-13
- Human amniotic mesenchymal stem cell-derived induced pluripotent stem cells may generate a universal source of cardiac cells. Stem Cells Dev. 2012; (15): 2798-808
- In vivo detection and treatment of ischemia-induced cardiac apoptosis using an MRI-detectable molecular probe and an alpha-adrenergic receptor agonist. J Cardiovasc Magn Reson. 2012: P67
- Is reliable in vivo detection of stem cell viability possible in a large animal model of myocardial injury? Circulation. 2012; (4): 388-90
- Manganese-enhanced MRI detects live human amnion-derived mesenchymal stem cells in vivo after transplantation and restoration of myocardial function in a pig ischemia-reperfusion injury model. J Cardiovasc Magn Reson. 2012: P62
Help